CSPC Pharmaceutical Group Ltd. logo

CSPC Pharmaceutical Group Ltd. (29362)

Market Open
18 Aug, 03:11
HKEX HKEX
0. 07
HKD
-0.01
-9.4595%
HKD
- Market Cap
- P/E Ratio
- Div Yield
950,000 Volume
- Eps
0.07 HKD
Previous Close
Add Transaction
Day Range
0.07 0.08
Year Range
0.05 1
Want to track 29362 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

29362 trading today lower at 0.07 HKD, a decrease of -9.4595% from yesterday's close, completing a monthly increase of 26.4151% or 0.01 HKD. Over the past 12 months, 29362 stock lost -37.3832%.
29362 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

29362 Chart

CSPC Pharmaceutical Group Ltd. (29362) FAQ

What is the stock price today?

The current price is 0.07 HKD.

On which exchange is it traded?

CSPC Pharmaceutical Group Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 29362.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has CSPC Pharmaceutical Group Ltd. ever had a stock split?

No, there has never been a stock split.

CSPC Pharmaceutical Group Ltd. Profile

- Industry
- Sector
- CEO
HKEX Exchange
- ISIN
Hong Kong Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

CSPC Pharmaceutical Group Ltd. stands as a pioneering and influential entity within the pharmaceutical sphere, primarily focusing on research, development, manufacturing, and distribution of an extensive assortment of pharmaceutical products. As a major participant, CSPC Pharmaceutical caters to various healthcare necessities through its broad portfolio, which encompasses innovative drugs, generics, and over-the-counter (OTC) medications. The company is notably active in therapeutic areas such as cardiovascular, oncology, anti-infectives, and nervous system treatments, significantly contributing to improved health outcomes. With its headquarters in China, CSPC Pharmaceutical is a leader in pharmaceutical advancements, dedicating considerable investment in research and development to promote the creation of innovative therapies. Its considerable market presence and strategic partnerships highlight its impact in the Asian markets and internationally. CSPC Pharmaceutical’s dedication to quality, affordability, and accessibility of healthcare solutions mirrors its ambition to enhance lives and further healthcare advancements worldwide.

Products and Services

  • Innovative Drugs - CSPC Pharmaceutical invests heavily in the research and development of innovative drugs that target unmet medical needs, particularly focusing on areas such as oncology and cardiovascular diseases. These drugs aim to offer new therapies that improve patient outcomes and quality of life.
  • Generics - The company produces high-quality generic pharmaceuticals, providing cost-effective alternatives to brand-name medication. This segment ensures wider access to essential medications, supporting global healthcare systems by offering effective and affordable treatment options.
  • Over-The-Counter (OTC) Medications - CSPC Pharmaceutical offers a variety of OTC medications, enabling consumers to address common health issues promptly without the need for a prescription. This range includes pain relievers, cold and allergy medications, and digestive aids, facilitating everyday healthcare needs.
  • Therapeutic Area Focus - With a strong emphasis on therapeutic areas such as cardiovascular, oncology, anti-infectives, and nervous system treatments, CSPC Pharmaceutical plays a crucial role in addressing some of the most challenging health concerns. Through its diverse portfolio, the company contributes significantly to enhancing treatment options and patient care in these critical areas.

Contact Information

Address: -
Phone: -